# Abu Dhabi’s M42 partners with Botswana health ministry, marking Africa entry — retained record

> Retained news record from news:semafor.

Canonical: https://highsignal.app/data/records/fe0ad848ba060692

[← sources](https://highsignal.app/data)


source: [news](https://highsignal.app/data/news) (news:semafor)  published 2026-08-26 13:02 ingested 2026-08-26 20:22

[original source ↗](https://www.semafor.com/article/08/26/2026/abu-dhabis-m42-to-roll-out-genomics-program-in-botswana)

## retained text



```
Abu Dhabi healthcare company M42 signed a 10-year contract with the government of Botswana to roll out a national genomics program, digitize health records, and bolster access to medicines. The deal comes as the G42 and Mubadala-backed firm has sought to expand in the Global South, where it sees “a distinct opportunity for nations to leapfrog legacy systems,” CEO Dimitris Moulavasilis said in a statement seen by Semafor.
The partnership with the Botswana Ministry of Health will include a population-level genomic sequencing effort, which can provide a trove of data and help screen for treatable conditions, and aims to improve pharmaceutical and medical supply chains with Mubadala’s life sciences unit Mubadala Bio. A timeline for the genomics project wasn’t given.
The deal is among the UAE’s more significant commercial bets on healthcare and M42’s first government-level agreement in Africa, which carries an outsize disease burden relative to its healthcare resources.
```



document fetched 2026-08-27 13:04 · canonical https://semafor.com/article/08/26/2026/abu-dhabis-m42-to-roll-out-genomics-program-in-botswana